Towards more efficient ways to diagnose cancer

Dr Muy-Teck Teh obtained his BSc and PhD from King’s College London followed by two postdoctoral research positions before being appointed a tenured lectureship at Queen Mary University of London. He leads a research group investigating cancer biomarkers and novel diagnostic methods with the overarching aim of personalising cancer treatment based on individual molecular signatures. In 2019, he patented the world first FOXM1-based digital molecular cancer test ‘quantitative malignancy diagnostic system (qMIDS)’ for the early detection of oral cancer.